Capital that returns
the world we want.

Modern capital structurally misprices what humans value. We’re changing that.

Investment Approach

Human beings all crave the experience of feeling safe and alive in our bodies.

Most businesses today are not set up to create this experience, because the economic system they’re in is reactive and extractive.

However, there is a formula for companies that create a differentiated somatic experience at scale.

Which creates durable returns that compound over decades.

And doing so is also the only way to return markets to a force for human flourishing.

Our Criteria

We make bets based on whether they bring us closer to the world we want, using three criteria.

1

Founders: Building from contribution.

Founder Profile

We look for founders who…

  • Ground their product's contribution in their own direct lived experience.
  • Can directly connect their product to human flourishing as a core feature, not a marketing benefit or aspiration.
  • Are willing to proactively structure their company against known extractive failure modes.
2

Opportunity: Felt differentiation in large markets.

Market Dynamics

We look for opportunities where…

  • There is substantial frustration with how incumbents make their customers feel.
  • The product or service has a significant impact on the nervous system.
  • It is possible to measure drift towards extraction, whether through existing or innovative means.
3

Protection: Proactive anti-extraction structures.

Structural Protection

We only invest when…

  • Relational equity ownership is structurally preserved, meaning that the company never ends up in the hands of detached owners who look at it through a spreadsheet first.
  • Drift is legible to customers and/or counterparties, in such a way that it materially weakens the company’s core competitive position.
  • Owners accept scale discipline, including willingness misaligned capital or growth pathways, even when the financial case looks promising.
Our Edge
We Exploit A Gap

Few businesses organize themselves around somatic impact.

Fewer still have built a capability to do so.

Our Strategy SOMATIC GROUNDING COMMERCIAL FOUNDATION Where weplay The intersection of the two is sparsely populated.We’re betting on that gap.
We Nurture Creation

Most funders back exits. We back a world.

That’s why we run a greenhouse, not a portfolio.

A Seedbank

We’re constantly cultivating hypotheses, business plans, and a network of grounded humans who can make them real.

A Greenhouse

We give founders structured spaciousness to tune their somatic product-market fit before we pressure them to scale.

Infrastructure

Once our founders validate product-market fit, we build the infrastructure of the company around them, so they can grow without being consumed by a reactive system.

We Model Known Failure Modes

Extractive drift is predictable. Once it happens, somatic differentiation weakens.

Founder Compromise

Early on, many founders combine a genuine impulse to contribute to human flourishing with the idea that doing so should maximize their money. We look for ones who are more contribution-first, not reward-first.

Succession & Exit

Many entrepreneurs and investors build businesses to exit, which almost always leads to ownership who view the business through an extractive lens. Our investments are explicitly structured to avoid these outcomes.

Structural Extraction

Even well-intentioned founders often create extractive incentives, often by over-prioritizing growth, or taking on disconnected capital. These outcomes are avoidable proactively.

Fund Structure

A seed play, where the container matters.

1

The Investment

The Seedbank
~100 explorations, pre-investment.
Greenhouse
~20 bets, $250K–$500K.
Seed
~10 follow-ons, $1M–$2M.
2

The Bet

Sectors
Pan-industry with high incumbent frustration: physical spaces, food & beverage, health & wellness, consumer packaged goods, retail, finance, tech, media.
What We're Building
The first generation of companies organized around somatic state.
3

The Return

Horizon
Patient capital. Long-cycle, structurally aligned with what we’re building.
Profile
Targetting low- to mid-teens IRR, while outperforming philanthropy on impact.

Curious?

Reach out, we’d love to have a conversation.